WallStreetZenWallStreetZen

NASDAQ: MYGN
Myriad Genetics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Myriad Genetics earnings were -$395.2M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest MYGN earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$330.5M, up 330,400% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MYGN reported annual earnings of -$127.3M, with -51.7% growth.

MYGN earnings history

Current Revenue
$832.9M
Current Earnings
-$395.2M
Current Profit Margin
-47.4%

MYGN Return on Equity

Current Company
-62.6%
Current Industry
-3.9%
Current Market
31.7%
MYGN's Return on Equity (-62.6%)... subscribe to Premium to read more.
High Return on Equity Performance

MYGN undefined

Current Company
-41.7%
Current Industry
7.7%
MYGN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when MYGN announces earnings.

MYGN undefined

Current Company
-87.24%
Current Industry
15.8%
MYGN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MYGN vs Diagnostic & Research Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MYGN-$346.90M-$395.20MN/A-$4.28
FLGT-$32.90M-$51.02MN/A-$1.66
CSTL$32.57M-$9.47MN/A-$0.31
LAB-$95.89M-$120.50MN/A-$0.31
CDNA$60.36M$51.68MN/A$1.00
View Top Diagnostic & Research Stocks

Myriad Genetics Earnings Reports & History FAQ

What were Myriad Genetics's earnings last quarter?

On MYGN's earnings call on Invalid Date, Myriad Genetics (NASDAQ: MYGN) reported Q2 2025 earnings per share (EPS) of -$3.57, up 770.73% year over year. Total MYGN earnings for the quarter were -$330.50 million. In the same quarter last year, Myriad Genetics's earnings per share (EPS) was -$0.41.

If you're new to stock investing, here's how to buy Myriad Genetics stock.

Is Myriad Genetics profitable or losing money?

As of the last Myriad Genetics earnings report, Myriad Genetics is currently losing money. Myriad Genetics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$395.20 million, a 154.64% increase year over year.

What was MYGN's earnings growth in the past year?

As of Myriad Genetics's earnings date in Invalid Date, Myriad Genetics's earnings has grown year over year. MYGN earnings in the past year totalled -$395.20 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.